Biomedical Textiles Market Report 2026

The biomedical textiles market size has grown strongly in recent years. It will grow from $17.69 billion in 2025 to $19.35 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising surgical procedure volumes, increasing prevalence of chronic diseases, expansion of hospital infrastructure, growing use of wound care products, advancements in textile manufacturing technologies.

The biomedical textiles market size is expected to see strong growth in the next few years. It will grow to $27.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of bioresorbable materials, rising demand for minimally invasive surgical solutions, expansion of smart healthcare textiles, growing investments in medical device innovation, increasing focus on infection prevention. Major trends in the forecast period include increasing adoption of advanced implantable textile materials, rising demand for antimicrobial medical fabrics, growing use of biodegradable biomedical fibers, expansion of smart and functional medical textiles, enhanced focus on patient comfort and safety.

The increasing healthcare expenditure is expected to drive the growth of the biomedical textiles market in the coming years. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical equipment, pharmaceuticals, hospital care, physician services, and other healthcare-related costs. It directly impacts investments in advanced medical treatments, technologies, and healthcare infrastructure. The rising healthcare expenditure has led to greater investments in advanced medical treatments and technologies, further boosting the demand for specialized biomedical textile materials. For example, in November 2025, the Organisation for Economic Co-operation and Development, a France-based intergovernmental economic organization, reported that in 2024, average health spending in OECD countries was estimated at nearly USD 6,000 per capita (adjusted for differences in purchasing power), with the United States being the highest spender. Thus, increasing healthcare expenditures are fueling the growth of the biomedical textiles market.

Major companies in the biomedical textiles market are concentrating on forming strategic collaborations to launch smart textile platforms for the development of biomedical textiles. These alliances enable companies to combine their expertise in creating innovative platforms that incorporate medicine, wellness, and health benefits into clothing. For example, in August 2023, Nufabrx, a US-based biomedical textile firm, collaborated with Enventys Partners, a US-based vertically integrated product development, crowdfunding, and inbound marketing agency, to launch HealthWear, an advanced platform technology that integrates medicine, wellness, and health benefits into clothing. Active chemicals in textile products are directly embedded into this proprietary smart-textile platform. When garments are knitted as part of HealthWear, they consistently deliver small amounts of topical medications to the skin, activated by body heat and/or moisture. Even after repeated wearing, use, and laundering, garments created with HealthWear technology continue to provide therapeutic care at effective levels.

In March 2023, Riverpoint Medical, a U.S.-based medical device company focusing on surgical scaffolds and textile-based implants, signed an exclusive licensing agreement with DSM Biomedical to utilize its proprietary osteoconductive (OC) coating technology. Through this collaboration, Riverpoint plans to integrate DSM’s OC coating into its implantable textile-based scaffolds and grafts to support bone in-growth and improve regenerative performance. DSM Biomedical, a Netherlands-based biomaterials company, offers advanced osteoconductive coating technologies designed for medical implants and tissue engineering applications, facilitating enhanced cellular integration and better long-term stability for textile implants.

Major companies operating in the biomedical textiles market are Confluent Medical Technologies, Cardinal Health Inc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Smith & Nephew PLC, Medline Industries Inc, 3M Company, ATEX Technologies, Integra Life Sciences Corporation, Paul Hartmann AG, BSN Medical GmbH, Bally Ribbon Mills, Asahi Kasei Corporation, Freudenberg Medical LLC, Halyard Health, Kimberly-Clark Corporation, Milliken & Company, Mölnlycke Health Care AB, Precision Fabrics Group Inc., Secant Group LLC, Stradis Healthcare, Tietex International Ltd., Trelleborg AB, Vestagen Protective Technologies Inc., W.L. Gore & Associates Inc., Welspun Group, Zimmer Biomet Holdings.

North America was the largest region in the biomedical textiles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomedical textiles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biomedical textiles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the biomedical textiles market by increasing costs of imported specialty fibers, polymers, coatings, and textile processing machinery used in implantable and non-implantable products. Medical device manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on textile exports. These tariffs are increasing production costs and pricing pressures. However, they are also encouraging local textile manufacturing, regional material sourcing, and innovation in cost-effective biomedical fabric solutions.

The biomedical textiles market research report is one of a series of new reports that provides biomedical textiles market statistics, including biomedical textiles industry global market size, regional shares, competitors with a biomedical textiles market share, detailed biomedical textiles market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical textiles industry. This biomedical textiles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biomedical textiles are textile structures composed of either synthetic or natural fibers. These advanced materials are resistant to fungi, fire, bacteria, dirt, and water. They are used as medical devices, either within or outside the biological environment, to enhance the patient's health.

The primary product categories in biomedical textiles are non-implantable and implantable. Non-implantable biomedical textiles are utilized for external wound dressings. These textiles are applied externally to the body and may or may not come into direct contact with the skin. They are manufactured using various fabrics, including non-woven, woven, and knitted biomedical textiles, and the fiber types consist of both non-biodegradable and biodegradable materials. Key applications include ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and treatment, along with other uses, and they are employed by hospitals, ambulatory centers, clinics, community healthcare, and other end users.

The biomedical textiles market consists of sales of textiles for sutures & ligatures, vascular implants, soft tissue implants, hard tissue implants and hernia repair. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.